NeuroMetrix Inc. [NASDAQ: NURO] price surged by 6.67 percent to reach at $0.13. A sum of 10458309 shares traded at recent session while its average daily volume was at 1.12M shares. NeuroMetrix Inc. shares reached a high of $3.35 and dropped to a low of $1.8492 until finishing in the latest session at $2.08.
Guru’s Opinion on NeuroMetrix Inc. [NURO]:
H.C. Wainwright have made an estimate for NeuroMetrix Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 20, 2017. While these analysts kept the previous recommendation, Rodman & Renshaw raised their target price to Buy. The new note on the price target was released on June 28, 2016, representing the official price target for NeuroMetrix Inc. stock. Previously, the target price had yet another raise to $2, while Maxim Group analysts kept a Buy rating on NURO stock.
Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.
The Average True Range (ATR) for NeuroMetrix Inc. is set at 0.30, with the Price to Sales ratio for NURO stock in the period of the last 12 months amounting to 0.68. The Price to Book ratio for the last quarter was 1.20, with the Price to Cash per share for the same quarter was set at 1.04.
NURO Stock Performance Analysis:
NeuroMetrix Inc. [NURO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.46. With this latest performance, NURO shares dropped by -11.49% in over the last four-week period, additionally sinking by -59.92% over the last 6 months – not to mention a drop of -64.44% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NURO stock in for the last two-week period is set at 49.55, with the RSI for the last a single of trading hit 47.83, and the three-weeks RSI is set at 47.81 for NeuroMetrix Inc. [NURO]. The present Moving Average for the last 50 days of trading for this stock 2.20, while it was recorded at 1.99 for the last single week of trading, and 2.98 for the last 200 days.
Insight into NeuroMetrix Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and NeuroMetrix Inc. [NURO] shares currently have an operating margin of -91.82 and a Gross Margin at +44.66. NeuroMetrix Inc.’s Net Margin is presently recorded at -40.69.
Return on Total Capital for NURO is now -168.04, given the latest momentum, and Return on Invested Capital for the company is -79.06. Return on Equity for this stock declined to -87.46, with Return on Assets sitting at -39.70. When it comes to the capital structure of this company, NeuroMetrix Inc. [NURO] has a Total Debt to Total Equity ratio set at 59.49. Additionally, NURO Total Debt to Total Capital is recorded at 37.30, with Total Debt to Total Assets ending up at 21.83. Long-Term Debt to Equity for the company is recorded at 36.23, with the Long-Term Debt to Total Capital now at 22.72.
Reflecting on the efficiency of the workforce at the company, NeuroMetrix Inc. [NURO] managed to generate an average of -$164,044 per employee. Receivables Turnover for the company is 11.81 with a Total Asset Turnover recorded at a value of 0.98.NeuroMetrix Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.70.
NURO Stock EPS
With the latest financial reports released by the company, NeuroMetrix Inc. posted 1.5/share EPS, while the average EPS was predicted by analysts to be reported at -1.5/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 200.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for NURO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for NeuroMetrix Inc. go to 15.00%.
NeuroMetrix Inc. [NURO] Insider Position Details
There are presently around $0 million, or 3.60% of NURO stock, in the hands of institutional investors. The top three institutional holders of NURO stocks are: SABBY MANAGEMENT, LLC with ownership of 82,250, which is approximately 28.757% of the company’s market cap and around 0.90% of the total institutional ownership; COASTAL INVESTMENT ADVISORS, INC., holding 11,025 shares of the stock with an approximate value of $21000.0 in NURO stocks shares; and BLACKROCK INC., currently with $3000.0 in NURO stock with ownership of nearly 0% of the company’s market capitalization.
Positions in NeuroMetrix Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 3 institutional holders increased their position in NeuroMetrix Inc. [NASDAQ:NURO] by around 18,622 shares. Additionally, 7 investors decreased positions by around 91,549 shares, while 1 investors held positions by with 15,116 shares. The mentioned changes placed institutional holdings at 95,055 shares, according to the latest SEC report filing. NURO stock had 2 new institutional investments in for a total of 252 shares, while 6 institutional investors sold positions of 80,449 shares during the same period.